Connecticut 2016 Regular Session

Connecticut House Bill HB05301

Introduced
2/18/16  
Introduced
2/18/16  
Refer
2/18/16  
Refer
2/18/16  
Report Pass
3/8/16  
Report Pass
3/8/16  
Refer
3/17/16  
Refer
3/17/16  
Report Pass
3/23/16  
Report Pass
3/23/16  
Refer
3/29/16  
Refer
3/29/16  
Report Pass
4/1/16  

Caption

An Act Concerning Opioid Analgesic Prescriptions Issued To Minors.

Impact

The enactment of HB 5301 is designed to mitigate the risk of opioid addiction among minors by ensuring that prescribing practitioners have a thorough understanding of the patient’s background and informing caregivers about potential dangers. This legislative measure aims to create a more responsible approach to prescribing controlled substances to young patients, which aligns with broader efforts to combat the opioid crisis in the state. By mandating these practices, the bill intends to enhance patient safeguarding and promote responsible prescribing habits in the medical community.

Summary

House Bill 5301, known as the Act Concerning Opioid Analgesic Prescriptions Issued to Minors, establishes new regulations governing how opioid prescriptions are administered to patients under the age of eighteen. The bill mandates that healthcare providers review a patient's medical history and assess any potential psychiatric or substance abuse issues before prescribing opioid analgesics. Importantly, it requires written consent from a parent or guardian when a minor is prescribed such medications, emphasizing the need for informed discussions about the risks associated with opioid use.

Sentiment

The sentiment around HB 5301 has been largely supportive, with stakeholders recognizing the importance of addressing the opioid epidemic, particularly as it pertains to younger populations. Supporters argue that the bill will play a critical role in fostering awareness about opioid dependency and ensuring that youths are not exposed to the risks of opioid misuse without adequate oversight. However, some critics express concern over the potential burden on prescribers and the administrative requirements imposed by the approval process, suggesting that these stipulations could complicate timely medical care for minors in need of pain management.

Contention

The main point of contention surrounding HB 5301 lies in the balance between safeguarding minors and ensuring timely access to pain relief. Critics argue that the additional requirements for parental consent and medical assessment could hinder immediate treatment in emergency situations, potentially delaying necessary care for youths. Conversely, supporters cite the bill as a necessary precaution, aiming to curtail prescription abuse and protect vulnerable populations from addiction risks as the state grapples with an ongoing public health crisis.

Companion Bills

No companion bills found.

Similar Bills

No similar bills found.